How Ebola and Marburg viruses battle the immune system
- 1 July 2007
- journal article
- review article
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 7 (7) , 556-567
- https://doi.org/10.1038/nri2098
Abstract
The filoviruses Ebola and Marburg have emerged in the past decade from relative obscurity to serve now as archetypes for some of the more intriguing and daunting challenges posed by such agents. Public imagination is captured by deadly outbreaks of these viruses and reinforced by the specter of bioterrorism. As research on these agents has accelerated, it has been found increasingly that filoviruses use a combination of familiar and apparently new ways to baffle and battle the immune system. Filoviruses have provided thereby a new lens through which to examine the immune system itself.Keywords
This publication has 109 references indexed in Scilit:
- Successful Topical Respiratory Tract Immunization of Primates against Ebola VirusJournal of Virology, 2007
- Proteolytic Processing of the Ebola Virus Glycoprotein Is Not Critical for Ebola Virus Replication in Nonhuman PrimatesJournal of Virology, 2007
- Activation of Triggering Receptor Expressed on Myeloid Cells-1 on Human Neutrophils by Marburg and Ebola VirusesJournal of Virology, 2006
- Marburgvirus Genomics and Association with a Large Hemorrhagic Fever Outbreak in AngolaJournal of Virology, 2006
- Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I SignalingJournal of Virology, 2006
- Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear AccumulationJournal of Virology, 2006
- Conserved Receptor-binding Domains of Lake Victoria Marburgvirus and Zaire Ebolavirus Bind a Common ReceptorJournal of Biological Chemistry, 2006
- Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPsPLoS Medicine, 2006
- Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus GlycoproteinJournal of Virology, 2006
- Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunityNature Reviews Immunology, 2004